Transintestinal and biliary cholesterol secretion both contribute to macrophage reverse cholesterol transport in rats - Brief report

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 37, Issue 4, 2017, Pages 643-646

  De Boer, Jan Freark ^a   Schonewille, Marleen ^a   Dikkers, Arne ^a   Koehorst, Martijn ^a   Havinga, Rick ^a   Kuipers, Folkert ^a   Tietge, Uwe J F ^a   Groen, Albert K ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Bile; Cholesterol; Intestines; Liver; Macrophages; Sterols

Indexed keywords

CHOLESTEROL; TRACER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT; BILE FLOW; BILE SECRETION; CANNULA; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DUODENUM; FECES; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSINTESTINAL CHOLESTEROL EXCRETION; ANIMAL; ANIMAL MODEL; BILE; BILIARY EXCRETION; CHEMISTRY; INTESTINAL EXCRETION; INTESTINAL SECRETIONS; MALE; METABOLISM; SECRETION (PROCESS); TIME FACTOR; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ANIMALS; BILE; BIOLOGICAL TRANSPORT; CHOLESTEROL; DUODENUM; FECES; HEPATOBILIARY ELIMINATION; INTESTINAL ELIMINATION; INTESTINAL SECRETIONS; MACROPHAGES; MALE; MODELS, ANIMAL; RATS, WISTAR; TIME FACTORS;

EID: 85013853601     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.308558     Document Type: Article

References (17)

1. Sorci-Thomas MG, Thomas MJ. Microdomains, inflammation, and atherosclerosis. Circ Res. 2016; 118: 679-691. doi: 10.1161/CIRCRESAHA.115.306246.
2. Kruth HS Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles. Curr Opin Lipidol. 2011; 22: 386-393. doi: 10.1097/MOL.0b013e32834adadb.
3. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature. 2008; 451: 904-913. doi: 10.1038/nature06796.
4. van der Veen JN, van Dijk TH, Vrins CL, van Meer H, Havinga R, Bijsterveld K, Tietge UJ, Groen AK, Kuipers F. Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol. J Biol Chem. 2009; 284: 19211-19219. doi: 10.1074/jbc.M109.014860.
5. Tietge UJ, Groen AK. Role the TICE?: advancing the concept of transintestinal cholesterol excretion. Arterioscler Thromb Vasc Biol. 2013; 33: 1452-1453. doi: 10.1161/ATVBAHA.113.301562.
6. Temel RE, Brown JM. A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion. Trends Pharmacol Sci. 2015; 36: 440-451. doi: 10.1016/j.tips.2015.04.002.
7. Jakulj L, van Dijk TH, de Boer JF, Kootte RS, Schonewille M, Paalvast Y, Boer T, Bloks VW, Boverhof R, Nieuwdorp M, Beuers UH, Stroes ES, Groen AK. Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion. Cell Metab. 2016; 24: 783-794. doi: 10.1016/j.cmet.2016.10.001.
8. de Boer JF, Schonewille M, Boesjes M, et al. Intestinal farnesoid x receptor controls transintestinal cholesterol excretion in mice [published online ahead of print January 5, 2017]. Gastroenterology. doi: 10.1053/j.gastro.2016.12.037. http://www.sciencedirect.com/science/article/pii/S0016508517300057. Accessed February 8, 2017.
9. Brufau G, Kuipers F, Lin Y, Trautwein EA, Groen AK. A reappraisal of the mechanism by which plant sterols promote neutral sterol loss in mice. PLoS One. 2011; 6: e21576. doi: 10.1371/journal.pone.0021576.
10. Le May C, Berger JM, Lespine A, Pillot B, Prieur X, Letessier E, Hussain MM, Collet X, Cariou B, Costet P. Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1. Arterioscler Thromb Vasc Biol. 2013; 33: 1484-1493. doi: 10.1161/ATVBAHA.112.300263.
11. Nijstad N, Gautier T, Briand F, Rader DJ, Tietge UJ. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. Gastroenterology. 2011; 140: 1043-1051. doi: 10.1053/j.gastro.2010.11.055.
12. Xie P, Jia L, Ma Y, Ou J, Miao H, Wang N, Guo F, Yazdanyar A, Jiang XC, Yu L. Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice. Arterioscler Thromb Vasc Biol. 2013; 33: 920-925. doi: 10.1161/ATVBAHA.112.301187.
13. Uto-Kondo H, Ayaori M, Sotherden GM, Nakaya K, Sasaki M, Yogo M, Komatsu T, Takiguchi S, Yakushiji E, Ogura M, Nishida T, Endo Y, Ikewaki K. Ezetimibe enhances macrophage reverse cholesterol transport in hamsters: contribution of hepato-biliary pathway. Biochim Biophys Acta. 2014; 1841: 1247-1255. doi: 10.1016/j.bbalip.2014.05.009.
14. Temel RE, Sawyer JK, Yu L, Lord C, Degirolamo C, McDaniel A, Marshall S, Wang N, Shah R, Rudel LL, Brown JM. Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Cell Metab. 2010; 12: 96-102. doi: 10.1016/j.cmet.2010.05.011.
15. van der Velde AE, Vrins CL, van den Oever K, Kunne C, Oude Elferink RP, Kuipers F, Groen AK. Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology. 2007; 133: 967-975. doi: 10.1053/j.gastro.2007.06.019.
16. Kuipers F, Havinga R, Bosschieter H, Toorop GP, Hindriks FR, Vonk RJ. Enterohepatic circulation in the rat. Gastroenterology. 1985; 88: 403-411.
17. Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008; 7: 678-693. doi: 10.1038/nrd2619.